Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 57 entries
Sorted by: Best Match Show Resources per page
Modified Sagnac interferometer for contact-free length measurement of a direct absorption cell.

Applied optics

Elandaloussi H, Rouillé C, Marie-Jeanne P, Janssen C.
PMID: 26974791
Appl Opt. 2016 Mar 10;55(8):1971-7. doi: 10.1364/AO.55.001971.

Accurate path length measurements in absorption cells are recurrent requirements in quantitative molecular absorption spectroscopy. A new twin path laser interferometer for length measurements in a simple direct path absorption geometry is presented, along with a full uncertainty budget....

Cite
Elandaloussi H, Rouillé C, Marie-Jeanne P, et al. Modified Sagnac interferometer for contact-free length measurement of a direct absorption cell. Appl Opt. 2016;55(8):1971-7doi: 10.1364/AO.55.001971.
Elandaloussi, H., Rouillé, C., Marie-Jeanne, P., & Janssen, C. (2016). Modified Sagnac interferometer for contact-free length measurement of a direct absorption cell. Applied optics, 55(8), 1971-7. https://doi.org/10.1364/AO.55.001971
Elandaloussi, Hadj, et al. "Modified Sagnac interferometer for contact-free length measurement of a direct absorption cell." Applied optics vol. 55,8 (2016): 1971-7. doi: https://doi.org/10.1364/AO.55.001971
Elandaloussi H, Rouillé C, Marie-Jeanne P, Janssen C. Modified Sagnac interferometer for contact-free length measurement of a direct absorption cell. Appl Opt. 2016 Mar 10;55(8):1971-7. doi: 10.1364/AO.55.001971. PMID: 26974791.
Copy Download .nbib Format: NLM
New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11).

Journal of biomedicine & biotechnology

El Andaloussi A, Bilhou-Nabera C.
PMID: 18273416
J Biomed Biotechnol. 2007;2007(7):92385. doi: 10.1155/2007/92385.

A Chronic myeloid leukaemia (CML) case with a new complex t(9;18;22)(q34;p11;q11) of a 29-year-old man is being reported. For the first time, this translocation has been characterized by karyotype complemented with fluorescence in situ hybridization (FISH). In CML, the...

Cite
El Andaloussi A, Bilhou-Nabera C. New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11). J Biomed Biotechnol. 2007;2007(7):92385doi: 10.1155/2007/92385.
El Andaloussi, A., & Bilhou-Nabera, C. (2007). New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11). Journal of biomedicine & biotechnology, 2007(7), 92385. https://doi.org/10.1155/2007/92385
El Andaloussi, Abdeljabar, and Bilhou-Nabera, Chrystele. "New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11)." Journal of biomedicine & biotechnology vol. 2007,7 (2007): 92385. doi: https://doi.org/10.1155/2007/92385
El Andaloussi A, Bilhou-Nabera C. New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11). J Biomed Biotechnol. 2007;2007(7):92385. doi: 10.1155/2007/92385. PMID: 18273416; PMCID: PMC2219519.
Copy Download .nbib Format: NLM
Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization.

ISRN pharmaceutics

Muñoz-Alarcón A, Guterstam P, Romero C, Behlke MA, Lennox KA, Wengel J, El Andaloussi S, Langel U.
PMID: 22474606
ISRN Pharm. 2012;2012:407154. doi: 10.5402/2012/407154. Epub 2012 Feb 07.

MicroRNAs are short, endogenous RNAs that direct posttranscriptional regulation of gene expression vital for many developmental and cellular functions. Implicated in the pathogenesis of several human diseases, this group of RNAs provides interesting targets for therapeutic intervention. Anti-microRNA oligonucleotides...

Cite
Muñoz-Alarcón A, Guterstam P, Romero C, et al. Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization. ISRN Pharm. 2012;2012:407154doi: 10.5402/2012/407154.
Muñoz-Alarcón, A., Guterstam, P., Romero, C., Behlke, M. A., Lennox, K. A., Wengel, J., El Andaloussi, S., & Langel, U. (2012). Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization. ISRN pharmaceutics, 2012407154. https://doi.org/10.5402/2012/407154
Muñoz-Alarcón, Andrés, et al. "Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization." ISRN pharmaceutics vol. 2012 (2012): 407154. doi: https://doi.org/10.5402/2012/407154
Muñoz-Alarcón A, Guterstam P, Romero C, Behlke MA, Lennox KA, Wengel J, El Andaloussi S, Langel U. Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization. ISRN Pharm. 2012;2012:407154. doi: 10.5402/2012/407154. Epub 2012 Feb 07. PMID: 22474606; PMCID: PMC3302052.
Copy Download .nbib Format: NLM
Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material.

Journal of extracellular vesicles

Görgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, Thalmann S, Welsh JA, Probst C, Guerin C, Boulanger CM, Jones JC, Hanenberg H, Erdbrügger U, Lannigan J, Ricklefs FL, El-Andaloussi S, Giebel B.
PMID: 30949308
J Extracell Vesicles. 2019 Mar 21;8(1):1587567. doi: 10.1080/20013078.2019.1587567. eCollection 2019.

Extracellular vesicles (EVs) mediate targeted cellular interactions in normal and pathophysiological conditions and are increasingly recognised as potential biomarkers, therapeutic agents and drug delivery vehicles. Based on their size and biogenesis, EVs are classified as exosomes, microvesicles and apoptotic...

Cite
Görgens A, Bremer M, Ferrer-Tur R, et al. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019;8(1):1587567doi: 10.1080/20013078.2019.1587567.
Görgens, A., Bremer, M., Ferrer-Tur, R., Murke, F., Tertel, T., Horn, P. A., Thalmann, S., Welsh, J. A., Probst, C., Guerin, C., Boulanger, C. M., Jones, J. C., Hanenberg, H., Erdbrügger, U., Lannigan, J., Ricklefs, F. L., El-Andaloussi, S., & Giebel, B. (2019). Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. Journal of extracellular vesicles, 8(1), 1587567. https://doi.org/10.1080/20013078.2019.1587567
Görgens, André, et al. "Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material." Journal of extracellular vesicles vol. 8,1 (2019): 1587567. doi: https://doi.org/10.1080/20013078.2019.1587567
Görgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, Thalmann S, Welsh JA, Probst C, Guerin C, Boulanger CM, Jones JC, Hanenberg H, Erdbrügger U, Lannigan J, Ricklefs FL, El-Andaloussi S, Giebel B. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019 Mar 21;8(1):1587567. doi: 10.1080/20013078.2019.1587567. eCollection 2019. PMID: 30949308; PMCID: PMC6442110.
Copy Download .nbib Format: NLM
Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein.

Molecular therapy : the journal of the American Society of Gene Therapy

Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel Ü.
PMID: 28192705
Mol Ther. 2008 Jan;16(1):115-123. doi: 10.1038/sj.mt.6300346. Epub 2016 Dec 07.

The tumor suppressor p14ARF is widely deregulated in many types of cancers and is believed to function as a failsafe mechanism, inhibiting proliferation and inducing apoptosis as cellular response to a high oncogene load. We have found that a...

Cite
Johansson HJ, El-Andaloussi S, Holm T, et al. Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. Mol Ther. 2016;16(1):115-123doi: 10.1038/sj.mt.6300346.
Johansson, H. J., El-Andaloussi, S., Holm, T., Mäe, M., Jänes, J., Maimets, T., & Langel, �. �. (2008). Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. Molecular therapy : the journal of the American Society of Gene Therapy, 16(1), 115-123. https://doi.org/10.1038/sj.mt.6300346
Johansson, Henrik J, et al. "Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein." Molecular therapy : the journal of the American Society of Gene Therapy vol. 16,1 (2008): 115-123. doi: https://doi.org/10.1038/sj.mt.6300346
Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel Ü. Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. Mol Ther. 2008 Jan;16(1):115-123. doi: 10.1038/sj.mt.6300346. Epub 2016 Dec 07. PMID: 28192705.
Copy Download .nbib Format: NLM
Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Tokhmafshan F, El Andalousi J, Murugapoopathy V, Fillion ML, Campillo S, Capolicchio JP, Jednak R, El Sherbiny M, Turpin S, Schalkwijk J, Matsumoto KI, Brophy PD, Gbadegesin RA, Gupta IR.
PMID: 31702543
Can Urol Assoc J. 2020 Apr;14(4):E128-E136. doi: 10.5489/cuaj.6068. Epub 2019 Nov 05.

INTRODUCTION: To consider alternative mechanisms that give rise to a refluxing ureterovesical junction (UVJ), we hypothesized that children with a common heritable urinary tract defect, vesicoureteric reflux (VUR), may have a defect in the extracellular matrix composition of the...

Cite
Tokhmafshan F, El Andalousi J, Murugapoopathy V, et al. Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants. Can Urol Assoc J. 2019;14(4):E128-E136doi: 10.5489/cuaj.6068.
Tokhmafshan, F., El Andalousi, J., Murugapoopathy, V., Fillion, M. L., Campillo, S., Capolicchio, J. P., Jednak, R., El Sherbiny, M., Turpin, S., Schalkwijk, J., Matsumoto, K. I., Brophy, P. D., Gbadegesin, R. A., & Gupta, I. R. (2020). Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 14(4), E128-E136. https://doi.org/10.5489/cuaj.6068
Tokhmafshan, Fatima, et al. "Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 14,4 (2020): E128-E136. doi: https://doi.org/10.5489/cuaj.6068
Tokhmafshan F, El Andalousi J, Murugapoopathy V, Fillion ML, Campillo S, Capolicchio JP, Jednak R, El Sherbiny M, Turpin S, Schalkwijk J, Matsumoto KI, Brophy PD, Gbadegesin RA, Gupta IR. Children with vesicoureteric reflux have joint hypermobility and occasional tenascin XB sequence variants. Can Urol Assoc J. 2020 Apr;14(4):E128-E136. doi: 10.5489/cuaj.6068. Epub 2019 Nov 05. PMID: 31702543; PMCID: PMC7124173.
Copy Download .nbib Format: NLM
Nonlinear Frequency-Sweep Correction of Tunable Electromagnetic Sources.

IEEE transactions on ultrasonics, ferroelectrics, and frequency control

Minissale M, Zanon-Willette T, Prokhorov I, Elandaloussi H, Janssen C.
PMID: 29993544
IEEE Trans Ultrason Ferroelectr Freq Control. 2018 Aug;65(8):1487-1491. doi: 10.1109/TUFFC.2018.2843183. Epub 2018 Jun 01.

Tunable electromagnetic (EM) sources, such as voltage-controlled oscillators, micro-electromechanical systems, or diode lasers are often required to be linear during frequency-sweep modulation. In many cases, it might also be sufficient that the degree of the nonlinearity can be well...

Cite
Minissale M, Zanon-Willette T, Prokhorov I, et al. Nonlinear Frequency-Sweep Correction of Tunable Electromagnetic Sources. IEEE Trans Ultrason Ferroelectr Freq Control. 2018;65(8):1487-1491doi: 10.1109/TUFFC.2018.2843183.
Minissale, M., Zanon-Willette, T., Prokhorov, I., Elandaloussi, H., & Janssen, C. (2018). Nonlinear Frequency-Sweep Correction of Tunable Electromagnetic Sources. IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 65(8), 1487-1491. https://doi.org/10.1109/TUFFC.2018.2843183
Minissale, Marco, et al. "Nonlinear Frequency-Sweep Correction of Tunable Electromagnetic Sources." IEEE transactions on ultrasonics, ferroelectrics, and frequency control vol. 65,8 (2018): 1487-1491. doi: https://doi.org/10.1109/TUFFC.2018.2843183
Minissale M, Zanon-Willette T, Prokhorov I, Elandaloussi H, Janssen C. Nonlinear Frequency-Sweep Correction of Tunable Electromagnetic Sources. IEEE Trans Ultrason Ferroelectr Freq Control. 2018 Aug;65(8):1487-1491. doi: 10.1109/TUFFC.2018.2843183. Epub 2018 Jun 01. PMID: 29993544.
Copy Download .nbib Format: NLM
Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale.

Frontiers in neuroscience

Lee YXF, Johansson H, Wood MJA, El Andaloussi S.
PMID: 31680809
Front Neurosci. 2019 Oct 18;13:1067. doi: 10.3389/fnins.2019.01067. eCollection 2019.

Extracellular vesicles (EVs) are nano-sized particles constitutively released from cells into all biological fluids. Interestingly, these vesicles contain genetic cargoes including proteins, RNA and bioactive lipids that can be functionally delivered and affect recipient cells. As a result, there...

Cite
Lee YXF, Johansson H, Wood MJA, et al. Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale. Front Neurosci. 2019;13:1067doi: 10.3389/fnins.2019.01067.
Lee, Y. X. F., Johansson, H., Wood, M. J. A., & El Andaloussi, S. (2019). Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale. Frontiers in neuroscience, 131067. https://doi.org/10.3389/fnins.2019.01067
Lee, Yi Xin Fiona, et al. "Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale." Frontiers in neuroscience vol. 13 (2019): 1067. doi: https://doi.org/10.3389/fnins.2019.01067
Lee YXF, Johansson H, Wood MJA, El Andaloussi S. Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale. Front Neurosci. 2019 Oct 18;13:1067. doi: 10.3389/fnins.2019.01067. eCollection 2019. PMID: 31680809; PMCID: PMC6813730.
Copy Download .nbib Format: NLM
GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Nature communications

Dar GH, Mendes CC, Kuan WL, Speciale AA, Conceição M, Görgens A, Uliyakina I, Lobo MJ, Lim WF, El Andaloussi S, Mäger I, Roberts TC, Barker RA, Goberdhan DCI, Wilson C, Wood MJA.
PMID: 34795295
Nat Commun. 2021 Nov 18;12(1):6666. doi: 10.1038/s41467-021-27056-3.

Extracellular vesicles (EVs) are biological nanoparticles with important roles in intercellular communication, and potential as drug delivery vehicles. Here we demonstrate a role for the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in EV assembly and secretion. We observe high levels...

Cite
Dar GH, Mendes CC, Kuan WL, et al. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain. Nat Commun. 2021;12(1):6666doi: 10.1038/s41467-021-27056-3.
Dar, G. H., Mendes, C. C., Kuan, W. L., Speciale, A. A., Conceição, M., Görgens, A., Uliyakina, I., Lobo, M. J., Lim, W. F., El Andaloussi, S., Mäger, I., Roberts, T. C., Barker, R. A., Goberdhan, D. C. I., Wilson, C., & Wood, M. J. A. (2021). GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain. Nature communications, 12(1), 6666. https://doi.org/10.1038/s41467-021-27056-3
Dar, Ghulam Hassan, et al. "GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain." Nature communications vol. 12,1 (2021): 6666. doi: https://doi.org/10.1038/s41467-021-27056-3
Dar GH, Mendes CC, Kuan WL, Speciale AA, Conceição M, Görgens A, Uliyakina I, Lobo MJ, Lim WF, El Andaloussi S, Mäger I, Roberts TC, Barker RA, Goberdhan DCI, Wilson C, Wood MJA. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain. Nat Commun. 2021 Nov 18;12(1):6666. doi: 10.1038/s41467-021-27056-3. PMID: 34795295; PMCID: PMC8602309.
Copy Download .nbib Format: NLM
Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer.

Journal of extracellular vesicles

Hagey DW, Kordes M, Görgens A, Mowoe MO, Nordin JZ, Moro CF, Löhr JM, El Andaloussi S.
PMID: 34595842
J Extracell Vesicles. 2021 Oct;10(12):e12142. doi: 10.1002/jev2.12142.

Up to now, the field of liquid biopsies has focused on circulating tumour DNA and cells, though extracellular vesicles (EVs) have been of increasing interest in recent years. Thus, reported sources of tumour-derived nucleic acids include leukocytes, platelets and...

Cite
Hagey DW, Kordes M, Görgens A, et al. Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer. J Extracell Vesicles. 2021;10(12):e12142doi: 10.1002/jev2.12142.
Hagey, D. W., Kordes, M., Görgens, A., Mowoe, M. O., Nordin, J. Z., Moro, C. F., Löhr, J. M., & El Andaloussi, S. (2021). Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer. Journal of extracellular vesicles, 10(12), e12142. https://doi.org/10.1002/jev2.12142
Hagey, Daniel W, et al. "Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer." Journal of extracellular vesicles vol. 10,12 (2021): e12142. doi: https://doi.org/10.1002/jev2.12142
Hagey DW, Kordes M, Görgens A, Mowoe MO, Nordin JZ, Moro CF, Löhr JM, El Andaloussi S. Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer. J Extracell Vesicles. 2021 Oct;10(12):e12142. doi: 10.1002/jev2.12142. PMID: 34595842; PMCID: PMC8485184.
Copy Download .nbib Format: NLM
Correction to: Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures.

Methods in molecular biology (Clifton, N.J.)

Sjöqvist S, Imafuku A, Gupta D, El Andaloussi S.
PMID: 31833008
Methods Mol Biol. 2020;2109:293. doi: 10.1007/7651_2019_274.

The original version of this chapter was inadvertently published with incorrect spelling of surname of the authors. The names should read Sebastian Sjöqvist, Aya Imafuku, Danu Gupta, and Samir EL Andaloussi, and not Sebastian Sjöqvist, Aya Imafuku, Dhanu Ghupta,...

Cite
Sjöqvist S, Imafuku A, Gupta D, et al. Correction to: Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures. Methods Mol Biol. 2020;2109:293doi: 10.1007/7651_2019_274.
Sjöqvist, S., Imafuku, A., Gupta, D., & El Andaloussi, S. (2020). Correction to: Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures. Methods in molecular biology (Clifton, N.J.), 2109293. https://doi.org/10.1007/7651_2019_274
Sjöqvist, Sebastian, et al. "Correction to: Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures." Methods in molecular biology (Clifton, N.J.) vol. 2109 (2020): 293. doi: https://doi.org/10.1007/7651_2019_274
Sjöqvist S, Imafuku A, Gupta D, El Andaloussi S. Correction to: Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures. Methods Mol Biol. 2020;2109:293. doi: 10.1007/7651_2019_274. PMID: 31833008.
Copy Download .nbib Format: NLM
GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Nature communications

Dar GH, Mendes CC, Kuan WL, Speciale AA, Conceição M, Görgens A, Uliyakina I, Lobo MJ, Lim WF, El Andaloussi S, Mäger I, Roberts TC, Barker RA, Goberdhan DCI, Wilson C, Wood MJA.
PMID: 34795295
Nat Commun. 2021 Nov 18;12(1):6666. doi: 10.1038/s41467-021-27056-3.

Extracellular vesicles (EVs) are biological nanoparticles with important roles in intercellular communication, and potential as drug delivery vehicles. Here we demonstrate a role for the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in EV assembly and secretion. We observe high levels...

Cite
Dar GH, Mendes CC, Kuan WL, et al. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain. Nat Commun. 2021;12(1):6666doi: 10.1038/s41467-021-27056-3.
Dar, G. H., Mendes, C. C., Kuan, W. L., Speciale, A. A., Conceição, M., Görgens, A., Uliyakina, I., Lobo, M. J., Lim, W. F., El Andaloussi, S., Mäger, I., Roberts, T. C., Barker, R. A., Goberdhan, D. C. I., Wilson, C., & Wood, M. J. A. (2021). GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain. Nature communications, 12(1), 6666. https://doi.org/10.1038/s41467-021-27056-3
Dar, Ghulam Hassan, et al. "GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain." Nature communications vol. 12,1 (2021): 6666. doi: https://doi.org/10.1038/s41467-021-27056-3
Dar GH, Mendes CC, Kuan WL, Speciale AA, Conceição M, Görgens A, Uliyakina I, Lobo MJ, Lim WF, El Andaloussi S, Mäger I, Roberts TC, Barker RA, Goberdhan DCI, Wilson C, Wood MJA. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain. Nat Commun. 2021 Nov 18;12(1):6666. doi: 10.1038/s41467-021-27056-3. PMID: 34795295; PMCID: PMC8602309.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 57 entries